Takashi Ebihara

7PUBLICATIONS
41CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGenetic immunologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 12, 2026
CNOT3 supports ILC2 differentiation and function by destabilizing Tbx21 and Rorc transcripts.

|Mar 05, 2026
PD-1 genetic fate mapping uncovers immune cell diversity mediating the efficacy of combined PD-1 blockade and chemotherapy.

Ayuko Yamaguchi, Haruka Suzuki, Shunsuke Takasuga

|Feb 19, 2026
Phosphorylation of Runx protein controls helper CD4+ T cell versus cytotoxic CD8+ T cell lineage choice.

Chihiro Ogawa, Kazuki Okuyama, Satoshi Kojo

|Nov 02, 2024
A mutant BCL11B-N440K protein interferes with BCL11A function during T lymphocyte and neuronal development.

Kazuki Okuyama, Motoi Yamashita, Artemis Koumoundourou

|Aug 28, 2023
CD45 alleviates airway inflammation and lung fibrosis by limiting expansion and activation of ILC2s.

Guangwei Cui, Akihiro Shimba, Jianshi Jin

|Apr 10, 2023
TIGIT mediates activation-induced cell death of ILC2s during chronic airway allergy.

Toshiki Yamada, Megumi Tatematsu, Shunsuke Takasuga

Pageof 2

Frequent Collaborators

2 joint publications

Ichiro Taniuchi

2 joint publications

Megumi Tatematsu

2 joint publications

Shunsuke Takasuga

2 joint publications

Akane Fuchimukai